In EBV-positive gastric carcinomas, the tumoral PD-L1(+) subgroup showed lower rates of overall survival (P < 0.05) (Fig. 4 and Supplemental Table 3), and recurrence-free survival (data not shown). The gene discussed is CD274; the disease is gastric carcinoma.